Xiaoli Li
Impact in
- Nephrology top 10%
- Renal Diseases and Glomerulopathies
Papers in
- Oncology 9
- Inflammatory Biomarkers in Disease Prognosis 4
- PARP inhibition in cancer therapy 2
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Li Yao (2 shared papers)Zilong Li (2 shared papers)Linlin Liu (1 shared paper)Liping Dong (1 shared paper)Yi Jiang (1 shared paper)Lining Wang (1 shared paper)Chunyan Yang (1 shared paper)Zhenghui Wang (2 shared papers)
- Journals
- Scientific Reports (2 papers)Frontiers in Immunology (2 papers)Medicine (2 papers)Frontiers in Oncology (2 papers)Therapeutics and Clinical Risk Management (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaoli Li
40 papers receiving 420 citations
Peers
Comparison fields: 5 of 76
- Nephrology 46
- Internal Medicine 13
- Cardiology and Cardiovascular Medicine 68
- Otorhinolaryngology 13
- Oncology 68
Countries citing papers authored by Xiaoli Li
This map shows the geographic impact of Xiaoli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Li more than expected).
Fields of papers citing papers by Xiaoli Li
This network shows the impact of papers produced by Xiaoli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Li. The network helps show where Xiaoli Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 59 | |
| 2 | 2018 | 37 | |
| 3 | 2019 | 36 | |
| 4 | 2012 | 34 | |
| 5 | 2018 | 25 | |
| 6 | 2019 | 20 | |
| 7 | 2012 | 20 | |
| 8 | 2013 | 18 | |
| 9 | 2017 | 17 | |
| 10 | 2020 | 16 | |
| 11 | 2014 | 15 | |
| 12 | 2021 | 14 | |
| 13 | 2013 | 14 | |
| 14 | [Clinical application of extracorporeal shock wave to repair and reconstruct osseous tissue framework in the treatment of avascular necrosis of the femoral head (ANFH)]. | 2010 | 10 |
| 15 | 2023 | 8 | |
| 16 | 2011 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2016 | 6 | |
| 20 | 2023 | 6 |
About Xiaoli Li
Xiaoli Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Molecular Biology and Organic Chemistry, having authored 43 papers that have together received 429 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Inflammatory mediators and NSAID effects (2 papers), PARP inhibition in cancer therapy (2 papers), Renal Diseases and Glomerulopathies (2 papers), Lung Cancer Treatments and Mutations (2 papers) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Nephrology (46 citations), Internal Medicine (13 citations), Cardiology and Cardiovascular Medicine (68 citations), Otorhinolaryngology (13 citations) and Oncology (68 citations). Xiaoli Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Li Yao, Zilong Li, Linlin Liu, Liping Dong, Yi Jiang, Lining Wang, Chunyan Yang, Zhenghui Wang, Yun Liu and Miao Liu. Their work appears in journals such as Scientific Reports, Frontiers in Immunology, Medicine, Frontiers in Oncology and Therapeutics and Clinical Risk Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.